MPLT
MapLight Therapeutics, Inc.NASDAQHealthcare$21.17+6.80%ClosedMarket Cap: $16.7M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
2.17
P/S
0.00
EV/EBITDA
0.14
DCF Value
$0.93
FCF Yield
-776.7%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-76.0%
ROA
-33.6%
ROIC
-36.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-83.4M | $-79.5M | $-1.81 | — |
| FY 2025 | $0.00 | -Infinity% | $-169.1M | $-161.2M | $-3.66 | — |
| Q3 2025 | $0.00 | -Infinity% | $-31.5M | $-29.4M | $-0.71 | — |
| Q2 2025 | $0.00 | -Infinity% | $-30.7M | $-29.8M | $-0.72 | — |
| Q1 2025 | $0.00 | -Infinity% | $-23.5M | $-22.3M | $-0.54 | — |
| Q4 2024 | $0.00 | NaN% | $-22.8M | $-21.2M | $-0.51 | — |
| FY 2024 | $0.00 | -Infinity% | $-82.9M | $-77.6M | $-1.87 | — |
| Q3 2024 | $0.00 | NaN% | $-20.9M | $-19.0M | $-0.46 | — |
| Q2 2024 | $0.00 | -Infinity% | $-20.0M | $-18.4M | $-0.44 | — |
| Q1 2024 | $0.00 | -Infinity% | $-19.3M | $-18.9M | $-0.46 | — |
| FY 2023 | $0.00 | -Infinity% | $-57.3M | $-55.7M | $-1.34 | — |
| Q1 2023 | $0.00 | -Infinity% | $-12.2M | $-12.0M | $-0.29 | — |